Dupixent AD, INN dupilumab

Enhertu low HER2, INN trastuzumab deruxtecan

Forxiga, INN Dapagliflozin (HF)

Jardiance, INN Empagliflozin (CKD)

Jardiance, INN Empagliflozin (HF)

Kyprolis MM, INN carfilzomib

Lynparza early breast cancer, INN olaparib

Nubeqa mHSPC, INN darolutamide

Ofev PF-ILD, INN nintedanib